Adam L. Berman is CEO and Co-Founder of TVA Medical, Inc., a clinical-stage medical device company that has developed an endovascular technology invented by Dr. William Cohn for patients with chronic kidney failure, as well as peripheral arterial disease. Adam has 20 years of experience in R&D, Sales and Operational leadership roles for start-up medical device companies creating minimally-invasive technology. He has been responsible for the development and commercialization of cardiovascular laser ablation systems, anastomotic devices and robotic surgical systems. His past companies include Coalescent Surgical, Inc. (now Medtronic), MedicalCV and Computer Motion, Inc. (now Intuitive Surgical). Adam received his BSE Magna Cum Laude in Biomedical Engineering from Rensselaer Polytechnic Institute and his MSE in Bioengineering from the University of Washington.